The Role of Regorafenib in Colorectal Cancer

October 29, 2013
S. Gail Eckhardt, MD

S. Gail Eckhardt, MD, discusses the role of regorafenib in colorectal cancer.

S. Gail Eckhardt, MD, professor and head of the Division of Medical Oncology at the University of Colorado Denver and Health Sciences Center, discusses the role of regorafenib in colorectal cancer.

Clinical Pearls

  • Regorafenib is a great option for community physicians who do not have access to clinical trials
  • The approval of regorafenib gives physicians a level of activity to improve upon but is only an incremental improvement for patients